CoreFirst Bank & Trust
- SEC CIK
- 0001845199
- Latest filing
- Aug 5, 2026
EW holding history
Edwards Lifesciences Corp in every 13F filed by CoreFirst Bank & Trust, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
EW overviewAll 13F holders of EWFull Q2 2026 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 14
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −2,400−100.0% | Sold out | Holders |
| Q2 2024 | 2,400 | $221.7K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 2,400 | $229.3K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 2,400 | $183.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 2,400 | $166.3K | 0.1% | −540−18.4% | Reduced | Holders |
| Q2 2023 | 2,940 | $277.3K | 0.2% | −540−15.5% | Reduced | Holders |
| Q1 2023 | 3,480 | $287.9K | 0.2% | 00.0% | Unchanged | Holders |
| Q4 2022 | 3,480 | $259.6K | 0.2% | +1,080+45.0% | Added | Holders |
| Q3 2022 | 2,400 | $198.0K | 0.2% | 00.0% | Unchanged | Holders |
| Q2 2022 | 2,400 | $228.0K | 0.2% | 00.0% | Unchanged | Holders |
| Q1 2022 | 2,400 | $283.0K | 0.2% | 00.0% | Unchanged | Holders |
| Q4 2021 | 2,400 | $311.0K | 0.2% | 00.0% | Unchanged | Holders |
| Q3 2021 | 2,400 | $272.0K | 0.2% | 00.0% | Unchanged | Holders |
| Q2 2021 | 2,400 | $249.0K | 0.2% | 00.0% | Unchanged | Holders |
| Q1 2021 | 2,400 | $201.0K | 0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.